Macrogenics, inc. (MGNX)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Operating activities
Cash flows from operating activities
Net loss

-44,724

-30,396

-44,631

-31,767

-45,017

-44,644

-34,029

-43,244

-49,536

105,727

-47,043

-40,655

-37,655

-34,783

-33,846

40,464

-30,363

-28,451

-15,442

-21,376

45,129

-19,018

-3,928

-12,259

-3,108

-3,205

6,604

-294

-3,365

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense

2,809

2,726

2,636

2,580

2,903

3,011

2,728

1,202

1,338

1,342

1,905

2,003

1,978

1,974

2,077

1,786

1,771

1,192

489

636

546

505

482

437

398

358

317

265

252

Stock-based compensation

4,491

5,490

5,398

4,884

3,799

4,352

4,573

4,163

3,432

3,680

4,001

3,602

3,461

3,039

3,002

3,123

3,001

2,216

2,098

1,902

1,631

995

856

781

612

468

137

112

144

Fair value adjustment of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

554

41

30

Changes in operating assets and liabilities:
Accounts receivable

-938

3,241

3,891

-503

-23,468

8,613

3,134

10,555

-6,361

11,448

203

-102

-671

-244

-75,367

75,864

1,287

-1,520

-1,590

2,615

-1,216

-2,380

2,670

899

-258

-277

-1,872

1,831

275

Prepaid expenses

1,345

-734

2,403

1,307

1,902

2,091

1,142

-155

177

-110

-747

-1,010

1,535

2,172

-2,471

2,079

-103

-178

-1,082

-551

-594

1,758

353

163

965

-132

1,033

13

-80

Other assets

-695

-1,043

-18,470

19,012

2,079

-4,713

3,782

5,551

-40

-94

-103

-146

81

-875

173

128

298

585

-300

0

0

1,331

-381

-1,165

1,394

-

-

-

0

Accounts payable

-2,286

1,700

1,685

-67

-2,531

3,019

-781

-8,499

7,815

594

-112

197

-2,223

2,365

222

33

-388

-1,035

688

409

-225

-2,719

411

-1,156

1,964

1,371

-321

-675

-944

Accrued expenses

-2,118

-1,379

-2,015

1,634

-4,297

-5,954

1,245

6,738

1,477

3,331

3,316

4,362

1,823

764

3,029

2,654

-1,788

2,355

815

1,304

-929

3,899

721

574

-848

2,644

-1

-320

24

Lease liabilities

-869

-966

3,616

-855

1,086

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease exit liability

-

-

-

-

-

-

0

0

-298

-

-405

-392

-379

-

-339

-1,646

-488

-460

-450

-1,987

-396

-372

-364

-355

-348

-163

-159

-155

-151

Deferred revenue

-2,248

-13,755

3,747

-5,431

-5,430

19,212

-2,436

-1,936

-1,435

9,199

-800

-801

-1,065

729

-1,741

-1,286

-1,893

-555

-3,856

-3,863

-3,949

-3,949

-9,927

7,770

9,423

-2,707

-7,197

-7,110

338

Deferred rent

-

-

-

-

-

-233

-222

-204

-312

-367

7,137

-329

-326

-288

-283

-283

-280

48

5,052

-426

-24

-38

-45

-45

-106

16

34

34

18

Other liabilities

515

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-44,142

-38,044

-17,388

-48,838

-30,000

-27,228

-36,980

-57,731

-31,295

111,845

-31,354

-30,755

-35,331

-28,329

49,786

-33,226

-31,910

-24,155

-7,634

-25,465

43,593

-20,164

-14,331

-4,150

5,886

-1,184

807

-9,946

-3,848

Cash flows from investing activities
Cash flows from investing activities
Purchases of marketable securities

61,186

50,221

71,873

60,708

81,597

12,711

33,548

62,039

24,452

45,998

32,187

0

56,937

78,065

67,305

119,276

83,116

142,910

0

0

0

-

-

-

-

-

-

-

-

Proceeds from sale and maturities of marketable securities

73,003

59,094

66,281

51,175

12,780

58,500

37,758

59,732

58,358

65,395

46,501

80,433

50,072

81,161

66,122

68,198

73,413

0

0

0

0

-

-

-

-

-

-

-

-

Purchases of property and equipment

1,253

1,247

780

587

1,675

715

4,216

5,504

14,519

10,758

9,850

7,303

1,492

1,062

1,980

5,508

2,831

2,780

2,608

2,812

997

1,658

672

795

447

924

1,161

450

425

Net cash provided by (used in) investing activities

10,564

7,626

-6,372

-10,120

-70,492

45,074

-6

-7,811

19,387

8,639

4,464

73,130

-8,357

2,034

-3,163

-56,586

-12,534

-145,690

-2,608

-2,812

-997

-1,658

-672

-795

-447

-924

-1,161

-450

-425

Cash flows from financing activities
Cash flows from financing activities
Proceeds from issuance of common stock, net of offering costs

0

0

0

0

118,657

0

0

103,259

0

-

-

-

-

-

-

-

-

0

140,775

0

62,692

-17

0

0

76,733

-

-

652

56

Proceeds from stock option exercises and ESPP purchases

162

297

37

633

348

735

132

496

629

449

28

559

108

531

1,011

127

224

279

207

170

255

258

180

238

68

-

-

-

-

Net cash provided by financing activities

162

297

37

633

119,005

475

132

103,755

629

359

1,147

33,734

108

492

1,011

127

224

250

140,982

170

62,947

222

180

238

76,801

85,020

142

652

56

Net change in cash and cash equivalents

-33,416

-30,121

-23,723

-58,325

18,513

18,321

-36,854

38,213

-11,279

120,843

-25,743

76,109

-43,580

-25,803

47,634

-89,685

-44,220

-169,595

130,740

-28,107

105,543

-21,600

-14,823

-4,707

82,240

82,912

-212

-9,744

-4,217

Supplemental Cash Flow Information [Abstract]
Right-of-use assets modified in exchange for operating lease obligations

0

0

4,420

0

1,988

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-